A Pilot Study of the Effect of L-Threodops on Rehabilitation Outcome of Stroke Patients

Neurorehabilitation and Neural Repair

Volumn 14, Issue 2, 2000, Pages 141-147

  Miyai, Ichiro ^a   Saito, Toshio ^a   Nozaki, Sonoko ^a   Kang, Jin ^a  

^a TONEYAMA NATIONAL HOSPITAL   (Japan)

Author keywords

DOPS; Rehabilitation; Stroke

Indexed keywords

THREO 3,4 DIHYDROXYPHENYLSERINE;

AGED; ARTICLE; CLINICAL ARTICLE; CLINICAL TRIAL; CONTROLLED CLINICAL TRIAL; CONTROLLED STUDY; DRUG EFFICACY; ENDURANCE; FEMALE; FUNCTIONAL ASSESSMENT; HUMAN; INDEPENDENCE; MALE; MOTOR PERFORMANCE; OCCUPATIONAL THERAPY; PHYSIOTHERAPY; STROKE; TREATMENT OUTCOME;

ACTIVITIES OF DAILY LIVING; ADMINISTRATION, ORAL; CEREBROVASCULAR ACCIDENT; DROXIDOPA; DRUG ADMINISTRATION SCHEDULE; HUMANS; OCCUPATIONAL THERAPY; PARESIS; PHYSICAL THERAPY MODALITIES; PILOT PROJECTS; TIME FACTORS; TREATMENT OUTCOME; WALKING;

EID: 0033813011     PISSN: 15459683     EISSN: 15526844     Source Type: Journal    
DOI: 10.1177/154596830001400207     Document Type: Article

References (28)

1. Feeney DM Gonzalez A Law WA. Amphetamine, haloperidol, experience interact to affect rate of recovery after motor cortex injury. Science 1982; 217: 855–857.
2. Crisostomo EA Duncan PW Propst M, et al. Evidence that amphetamine with physical therapy promotes recovery of motor function in stroke patients. Ann Neurol 1988; 23: 94–97.
3. Walker-Batson D Smith P Curtis S Unwin H Greenlee R. Amphetamine paired with physical therapy accelerates motor recovery following stroke: Further evidence. Stroke 1995; 26: 2254–2259.
4. Feeney DM Hovda DA. Amphetamine and apomorphine restore tactile placing after motor cortex injury in the cat. Psychopharmacology 1983; 79: 67–71.
5. Feeney DM Hovda DA. Reinstatement of binocular depth perception by amphetamine and visual experience after visual cortex ablation. Brain Res 1985; 342: 352–356.
6. Walker-Batson D. Pharmacotherapy in the treatment of aphasia. In: Goldstein LB,(ed. ). Restorative neurology: Advances in pharmacotherapy for recovery after stroke. Armonk: Futura Publishing, 1998: 257–270.
7. Grade C Redford B Chrostowski J Toussaint L Blackwell B. Methylphenidate in early poststroke recovery: A double-blind, placebo-controlled study. Arch Phys Med Rehabil 1998; 79: 1047–1050.
8. Kaelin DL Cifu DX Matthies B. Methylphenidate effect on attention deficit in the acutely brain-injured adult. Arch Phys Med Rehabil 1996; 77: 6–9.
9. Suzuki T Higa S Sakoda S, et al. Pharmacokinetic studies of oral L-threo-3,4-dihydroxyphenylserine in normal subjects and patients with familial amyloid polyneuropathy. Eur J Clin Pharmacol 1982; 23: 463–468.
10. Suzuki T Sakoda S Ueji M, et al. Treatment of parkinsonism with oral L-threo-3,4-dihydroxyphenylserine: A pharmacokinetic study. Neurology 1984; 34: 1446–1450.
11. Brannann T Bhardwaj A Yahr MD. L-Threodops increases extracellular norepinephrine levels in the brain: An in vivo study. Neurology 1990; 40: 1134–1135.
12. Keith RA Granger CV Hamilton BB Sherwin FS. The Functional Independence Measure: A new tool for rehabilitation. In: Eisenberg MG, Grzesiak RC,(eds. ). Advances in clinical rehabilitation. Vol 2. New York: Springer, 1987: 6–18.
13. Fugl-Meyer AR Jääsko L Leyman I Olsson S Steglind S. The post-stroke hemiplegic patient. A method for evaluation of physical performance. Scand J Rehabil Med 1975; 7: 13–31.
14. Brott T Adams H Olinger C. Measurement of acute cerebral infarction: A clinical examination scale. Stroke 1989; 20: 864–870.
15. Goldstein LB, Sygen in acute stroke study investigators. Common drug may influence motor recovery after stroke. Neurology 1995; 45: 865–871.
16. Feeney DM. Rehabilitation pharmacology. Noradrenergic enhancement of physical therapy. In: Ginsberg MD, Bogousslavsky J,(eds. ). Cerebrovascular disease. Pathophysiology, diagnosis, and management. Maiden, Mass.: Blackwell Science, 1998: 620–636.
17. Queen SA Chen MJ Feeney DM. D-Amphetamine attenuates decreased cerebral glucose utilization after unilateral sensorimotor cortex contusion in rats. Brain Res 1997; 777: 42–50.
18. Stroemer RP Kent TA Hulsebosch CE. Enhanced neocortical neural sprouting, synaptogenesis, and behavioral recovery with D-amphetamine therapy after neocortical infarction in rats. Stroke 1998; 29: 2381–2395.
19. Bütefisch CM Davis B Cohen LG. Pharmacological enhancement of plasticity in the human motor cortex. Neurology 1999; 52(Suppl 2): A15. Abstract.
20. Ziemann U Tam A Bütefisch C Cohen LG. Effect of dextroamphetamine on deafferentation- and stimulation-induced plasticity in human motor cortex. Neurology 1999; 52(Suppl 2): A468. Abstract.
21. Narabayashi H Kondo T Nagatsu T Hayashi A Suzuki T. DL-threo-3,4-dihydroxyphenylserine for freezing symptom in parkinsonism. Adv Neurol 1984; 40: 497–502.
22. Borucki SJ Landberg J Reding M. The effect of dextroamphetamine on motor recovery after stroke. Neurology 1992; 42 (Suppl); 329. Abstract.
23. Nishino K Kowada M Ito T. L-DOPS facilitated motor recovery in rat model and chronic stroke patients. Soc Neurosci Abs 1994; 20: 828.
24. Lipsy JR Robinson RG Pearlson GD, et al. Nortriptyline treatment of post-stroke depression: A double-blinded study. Lancet 1984; 1: 297–300.
25. Reding MJ Orto LA Winter SW, et al. Antidepressant therapy after stroke. A double-blind trial. Arch Neurol 1986; 43: 763–765.
26. Dam M Tonin P Boni D, et al. Effect of fluoxetine and maprotiline on functional recovery in poststroke hemiplegic patients undergoing rehabilitation therapy. Stroke 1996; 27: 1211–1214.
27. Miyai I Reding MJ. Effects of antidepressants on functional recovery following stroke: A double-blind study. J Neuro Rehab 1998; 12: 5–13.
28. Miyai I Reding M. Antidepressant effects on recovery. In: Goldstein LB,(ed. ). Restorative neurology: Advances in pharmacotherapy for recovery after stroke. Armonk: Futura Publishing, 1998: 271–286.